|
UCLA CHAMP Rationale and Design Reprint
Fonarow, G. C. and A. Gawlinski, Rational and Design of the
Cardiac Hospitalization Atherosclerosis Management Program at the University of
California Los Angeles, Am. J. Cardiol., 85:10A-17A, 2000.
UCLA CHAMP Results Reprint
Fonarow, G. C., A. Gawlinski, S. Moughrabi, and J. H.
Tillisch, Improved Treatment of Coronary Heart Disease by Implementation of a
Cardiac Hospitalization Atherosclerosis Management Program (CHAMP), Am. J.
Cardiol., 87:819-822, 2001.
Statin Therapy After Acute Myocardial
Infarction
Fonarow, G. C, Statin Therapy After Acute Myocardial
Infarction: Are We Adequately Treating High-risk Patients?, Cur.
Atheroscler. Reports, 4:99-106, 2002.
The Cardiovascular Roundtable, New Standards for
Secondary Prevention
Effects of ACE-Inhibitor on Cardiovascular Events in
High-risk Patients
The Heart Outcomes Prevention Evaluation Study Investigators,
Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on
Cardiovascular Events in High-Risk Patients, N. Engl. J. Med., 342:145-153,
2000.
Early Statin Treatment Following Acute Myocardial
Infarction
Stenestrand, U. and L. Wallentin, Early Statin Treatment
Following Acute Myocardial Infarction and 1-Year Survival, JAMA, 285:430-436,
2001.
Scandinavian Simvastatin Survival Study (4S) Follow-up
Study
Pedersen, T. R., L. Wilhelmsen, O. Faergeman, T. E.
Strandberg, G. Thorgeirsson, L. Troedsson, J. Kristianson, K. Berg, T. J. Cook,
T. Haghfelt, J. Kjekshus, T. Miettinen, A. G. Olsson, K. Pyorala, and H. Wedel,
Follow-Up Study of Patients Randomized in the Scandinavian Simvastatin Survival
Study (4S) of Cholesterol Lowering, Am. J. Cardiol., 86:257-262,
2000.
Preventing Mortality from Coronary Heart Disease with
Pravastatin
The Long-Term Intervention with Pravastatin in Ischemic
Disease (LIPID) Study Group, Prevention of Cardiovascular Events and Death with
Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial
Cholesterol Levels, N. Engl. J. Med., 339:1349-1357, 1998.
Statin Drug Treatment and Risk
of Coronary Disease (Meta-analysis)
LaRosa, J. C., J. He, and S. Vupputuri, Effect of Statins on
Risk of Coronary Disease. A Meta-analysis of Randomized Controlled Trials, JAMA,
282:2340-2346, 1999.
Self-Study from Web-Based and Printed Guideline
Materials
Bell, D. S., G. C. Fonarow, R. D. Hays, and C. M. Mangione,
Self-Study form Web-Based and Printed Guideline Materials. A Randomized,
Controlled Trial among Resident Physicians, Ann. Intern. Med., 132:938-946,
2000.
Cholesterol and Secondary Prevention
of Cardiovascular Disease
Lee, T. H., J. I. Cleeman, S. M. Grundy, C. Gillett, R. C.
Pasternak, J. Seidman, and C. Sennett, Clinical Goals and Performance Measures
for Cholesterol Management in Secondary Prevention of Coronary Heart Disease, JAMA,
283:94-98, 2000.
Undertreatment of Hyperlipidemia and Congestive Heart
Failure
Sueta, C. A., M. Chowdhury, S. J. Boccuzzi, S. C. Smith, Jr.,
C. M. Alexander, A. Londhe, A. Lulla, and R. J. Simpson, Jr., Analysis of the
Degree of Undertreatment of Hyperlipidemia and Congestive Heart Failure
Secondary to Coronary Artery Disease, Am. J. Cardiol., 83:1303-1307,
1999.
The Lipid Treatment Assessment Project (L-TAP)
Pearson, T. A., I. Laurora, H. Chu, and S. Kafonek, The Lipid
Treatment Assessment Project (L-TAP): A Multicenter Survey to Evaluate the
Percentages of Dyslipidemic Patients Receiving Lipid-Lowering Therapy and
Achieving Low-Density Lipoprotein Cholesterol Goals, Arch, Intern. Med., 160:459-467,
2000.
Utilization of Lipid-Lowering Medication
at Discharge in Patients with AMI
Fonarow, G. C., W. French, J. Parsons, H. Sun, and J.
Malmegren, Utilization of Lipid Lowering Medications at Discharge in Patients
with Acute Myocardial Infarction: Data from the National Registry of
Myocardial Infarction 3, Circulation, 102:38-44, 2001.
Guide to Preventive Cardiology for
Women
Mosca, L., S. M. Grundy, D. Judelson, K. King, M. Limacher,
S. Oparil, R. Pasternak, T. A. Pearson, R. F. Redberg, S. C. Smith, Jr., M.
Winston, and S. Zinberg, Guide to Preventive Cardiology for Women, Circulation,
99:2480-2484, 1999.
AHA Consensus Panel Statement on Vascular Disease Risk
Reduction
Executive Summary of the National Cholesterol
Education Program
Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults. JAMA, 286:2486-2497, 2001.
|
